Rajiv Lochan Tiwari

Rajiv Lochan Tiwari

Auto-generated profile, based on publicly available information

Rajiv Lochan Tiwari

Institute of Molecular Medicine and Stem Cell Aging, University of Ulm, Albert-Einstein-Allee 11c, D-89081 Ulm, Germany

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2007 in Medicinal Research Reviews
Verified
Journal Article
Closed access
PDF file
RTR.L. Tiwari
R.L. Tiwari
VSV. Singh
V. Singh
MBM.K. Barthwal
M.K. Barthwal

31 August 2015 in Cellular & Molecular Immunology
Verified
Journal Article
Closed access
PDF file
ASAnkita Singh
Ankita Singh
VSVishal Singh
Vishal Singh
RTRajiv L. Tiwari
Rajiv L. Tiwari
TCTulika Chandra
Tulika Chandra
AKAshutosh Kumar
Ashutosh Kumar
MBManoj K. Barthwal
Manoj K. Barthwal

3 March 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LTLars Thielecke
Lars Thielecke
TATim Aranyossy
Tim Aranyossy
ADAndreas Dahl
Andreas Dahl
RTRajiv Tiwari
Rajiv Tiwari
IRIngo Roeder
Ingo Roeder
KCKerstin Cornils
Kerstin Cornils
Genetic barcodes are increasingly used to track individual cells and to quantitatively assess their clonal contributions over time. Although barcode quantification relies entirely on counting sequencing reads, detailed studies about the method’s accuracy are still limited. We report on a systematic investigation of the relation between barcode abundance and resulting read counts after amplification and sequencing using cell-mixtures that contain barcodes with known frequencies (“miniBulks”). We evaluated the influence of protocol modifications to identify potential sources of error and elucidate possible limitations of the quantification approach. Based on these findings we designed an advanced barcode construct (BC32) to improved barcode calling and quantification, and to ensure a sensitive detection of even highly diluted barcodes. Our results emphasize the importance of using curated barcode libraries to obtain interpretable quantitative data and underline the need for rigorous analyses of any utilized barcode library in terms of reliability and reproducibility.

1 January 2009 in Current Vascular Pharmacology
Verified
Journal Article
Closed access
PDF file
VSVishal Singh
Vishal Singh
RTRajiv L. Tiwari
Rajiv L. Tiwari
MDMadhu Dikshit
Madhu Dikshit
MBManoj K. Barthwal
Manoj K. Barthwal
The recent failure of candidate drugs like cholesterol ester transfer protein (CETP) and acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors calls for a revised approach for screening anti-atherosclerotic drugs and development of new models of atherosclerosis. For this it is important to understand the mechanism of the disease in a particular model. Models simultaneously showing hyperlipidemia, inflammation and associated complications of diabetes and hypertension will serve the purpose better as they mimic the actual clinical condition. Besides this, analyzing candidate molecules in vivo, in vitro and at various levels of atherosclerosis progression is important. Models based on various cells and process involved in atherosclerosis should be used for screening candidate molecules. The challenge lies in bridging the gap between genetically friendly small animal and human-like bigger animal models. Sequencing of the mouse and human genome, development of a single nucleotide polymorphism (SNP) database and in silico quantitative trait loci (QTL) linkage analysis may enhance the understanding of atherosclerosis and help develop new therapeutic targets.

1 September 2011 in The Journal of Immunology
Verified
Journal Article
Closed access
RTRajiv Lochan Tiwari
Rajiv Lochan Tiwari
VSVishal Singh
Vishal Singh
ASAnkita Singh
Ankita Singh
MBManoj Kumar Barthwal
Manoj Kumar Barthwal
The role of IL-1R–associated kinase (IRAK)1 and its interaction with protein kinase C (PKC)δ in monocytes to regulate IL-1β production has not been reported so far. The present study thus investigates such mechanisms in the THP1 cell line and human monocytes. PMA treatment to THP1 cells induced CD11b, TLR2, TLR4, CD36, IRAK1, IRAK3, and IRAK4 expression, IRAK1 kinase activity, PKCδ and JNK phosphorylation, AP-1 and NF-κB activation, and secretory IL-1β production. Moreover, PMA-induced IL-1β production was significantly reduced in the presence of TLR2, TLR4, and CD11b Abs. Rottlerin, a PKCδ-specific inhibitor, significantly reduced PMA-induced IL-1β production as well as CD11b, TLR2 expression, and IRAK1–JNK activation. In PKCδ wild-type overexpressing THP1 cells, IRAK1 kinase activity and IL-1β production were significantly augmented, whereas recombinant inactive PKCδ and PKCδ small interfering RNA significantly inhibited basal and PMA-induced IRAK1 activation and IL-1β production. Endogenous PKCδ–IRAK1 interaction was observed in quiescent cells, and this interaction was regulated by PMA. IRAK1/4 inhibitors, their small interfering RNAs, and JNK inhibitor also attenuated PMA-induced IL-1β production. NF-κB activation inhibitor and SN50 peptide inhibitor, however, failed to affect PMA-induced IL-1β production. A similar role of IRAK1 in IL-1β production and its regulation by PKCδ was evident in the primary human monocytes, thus signifying the importance of our finding. To our knowledge, the results obtained demonstrate for the first time that IRAK1 and PKCδ functionally interact to regulate IL-1β production in monocytic cells. A novel mechanism of IL-1β production that involves TLR2, CD11b, and the PKCδ/IRAK1/JNK/AP-1 axis is thus being proposed.

1 July 2014 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
RTRajiv Lochan Tiwari
Rajiv Lochan Tiwari
VSVishal Singh
Vishal Singh
ASAnkita Singh
Ankita Singh
MRMinakshi Rana
Minakshi Rana
AVAnupam Verma
Anupam Verma
MBManoj Kumar Barthwal
Manoj Kumar Barthwal
It is well-established that over-accumulation of dietary cholesterol in the liver inhibits sterol-regulatory element binding protein (SREBP)-mediated LDL receptor (LDLR) gene transcription leading to a reduced hepatic LDLR mRNA level in hypercholesterolemic animals. However, it is unknown whether elevated cholesterol levels can elicit a cellular response to increase LDLR mRNA turnover to further repress LDLR expression in liver tissue. In the current study, we examined the effect of a high cholesterol diet on the hepatic expression of LDLR mRNA binding proteins in three different animal models and in cultured hepatic cells. Our results demonstrate that high cholesterol feeding specifically elevates the hepatic expression of LDLR mRNA decay promoting factor heterogeneous nuclear ribonucleoprotein (HNRNP)D without affecting expressions of other LDLR mRNA binding proteins in vivo and in vitro. Employing the approach of adenovirus-mediated gene knockdown, we further show that depletion of HNRNPD in the liver results in a marked reduction of serum LDL-cholesterol and a substantial increase in liver LDLR expression in hyperlipidemic mice. Additional studies of gene knockdown in albumin-luciferase-untranslated region (UTR) transgenic mice provide strong evidence supporting the essential role of 3′UTR in HNRNPD-mediated LDLR mRNA degradation in liver tissue. Altogether, this work identifies a novel posttranscriptional regulatory mechanism by which dietary cholesterol inhibits liver LDLR expression via inducing HNRNPD to accelerate LDLR mRNA degradation.